Evidence map›Paper›PMID 30621772›Full record

ArticleTrials2019

Evaluation of an intensive education program on the treatment of tobacco-use disorder for pharmacists: a study protocol for a randomized controlled trial.

Maguy Saffouh El Hajj, Ahmed Awaisu, Nadir Kheir, Mohamad Haniki Nik Mohamed, Rula Shami Haddad, Rana Ahmed Saleh, Noora Mohammed Alhamad, Ahmad Mohd Almulla, Ziyad R Mahfoud

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03518476 (Evaluation of an Intensive Education Program on the Treatment of Tobacco Use Disorder for Pharmacists), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03518476 nacompletednot on this map

Evaluation of an Intensive Education Program on the Treatment of Tobacco Use Disorder for Pharmacists: a Randomized Controlled Trial

TypeinterventionalSponsorQatar UniversityRan2018 to 2019Enrolled164ConditionsSmoking CessationArmsintensive multi-disciplinary education program on tobacco treatment for pharmacists, Control arm
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maguy Saffouh El HajjCollege of Pharmacy, Qatar University, Doha, 2713, Qatar. maguyh@qu.edu.qa.ORCID http://orcid.org/0000-0003-0770-4679
Ahmed AwaisuCollege of Pharmacy, Qatar University, Doha, 2713, Qatar.
Nadir KheirSchool of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Mohamad Haniki Nik MohamedKulliyyah of Pharmacy, International Islamic University Malaysia, 25200, Kuantan, Pahang, Malaysia.
Rula Shami HaddadCollege of Pharmacy, Qatar University, Doha, 2713, Qatar.
Rana Ahmed SalehCollege of Pharmacy, Qatar University, Doha, 2713, Qatar.
Noora Mohammed AlhamadCollege of Pharmacy, Qatar University, Doha, 2713, Qatar.
Ahmad Mohd AlmullaTobacco Control Center-WHO Collaborating Center, Hamad Medical Corporation, Doha, Qatar.
Ziyad R MahfoudWeil Cornell Medicine-Qatar, PO Box 24144, Doha, Qatar.

Funding

Qatar University Office of Research and Graduate Studies QUCG-CPH-2018\2019-3
6 · The paper itself

Abstract

backgroundTobacco use is presently responsible for the death of over seven million people across the world. In Qatar, it is one of the main causes of premature deaths and preventable diseases. To reduce tobacco use, Qatar has ratified the World Health Organization (WHO)'s Framework Convention on Tobacco Control (FCTC) and has implemented many tobacco-control initiatives. In spite of these measures, tobacco use is still considered a public health threat in Qatar. Pharmacists practicing in retail/community pharmacy settings are often the first port of call for individuals requiring general health advice. Evidence has proven that they have a pivotal role in health promotion and disease prevention including tobacco cessation. However, pharmacists in Qatar are not actively involved in tobacco control and many have not received any education or training about smoking cessation counseling in the past. In an effort to build the capacity of pharmacists towards tobacco control in Qatar, the aim of the proposed study is to design, implement, and evaluate an intensive education program on tobacco dependence treatment for pharmacists in Qatar. METHODS/

designThe study will be a prospective randomized controlled trial comparing an intensive tobacco-related education program versus non-tobacco-related training on pharmacists' tobacco-use-related knowledge, attitudes, self-efficacy, and skills. Community pharmacists practicing in Qatar will be eligible for participation in the study. A random sample of pharmacists will be selected for participation. Consenting participants will be randomly allocated to intervention or control groups. Participants in the intervention group will receive an intensive education program delivered by a multi-disciplinary group of educators, researchers, and clinicians with expertise in tobacco cessation. A short didactic session on a non-tobacco-related topic will be delivered to pharmacists in the control group. The study has two primary outcomes: post-intervention tobacco-related knowledge and post-intervention skills for tobacco cessation assessed using a multiple-choice-based evaluation instrument and an Objective Structured Clinical Examination (OSCE), respectively. The secondary study outcomes are post-intervention attitudes towards tobacco cessation and self-efficacy in tobacco-cessation interventions assessed using a survey instrument. An additional secondary study outcome is the post-intervention performance difference in relation to tobacco-cessation skills in the practice setting assessed using the simulated client approach. DISCUSSION: If demonstrated to be effective, this education program will be considered as a model that Qatar and the Middle East region can apply to overcome the burden of tobacco-use disorder.

trial registrationClinicalTrials.gov, ID: NCT03518476 . Registered on 8 May 2018. Version 1/22 June 2018.

Indexed as

Community Pharmacy ServicesEducation, Pharmacy, ContinuingPharmacistsData Interpretation, StatisticalHealth Knowledge, Attitudes, PracticeHumansOutcome Assessment, Health CareProspective StudiesRandomized Controlled Trials as TopicResearch DesignSample SizeSmoking CessationTobacco Use DisorderEducation programPharmacistQatarSmoking cessationTobacco control

Identifiers

PMID30621772
PMCPMC6324165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.